Zymeworks
ZYME
133 hedge funds and large institutions have $1.24B invested in Zymeworks in 2020 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 51 increasing their positions, 28 reducing their positions, and 23 closing their positions.
82% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 28
74% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 23
36% more call options, than puts
Call options by funds: $36.3M | Put options by funds: $26.7M
15% more funds holding
Funds holding: 116 → 133 (+17)
5% more capital invested
Capital invested by funds: $1.17B → $1.24B (+$62.3M)
2.92% more ownership
Funds ownership: 72.64% → 75.56% (+2.9%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$28.7M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
+$18.4M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.2M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$15.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$44.2M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$34.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$29.5M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$15.8M |
| 5 |
HM
HealthCor Management
New York
|
-$14.8M |
ZYME Hedge Fund Activity: Q2 2020 in Review
133 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2020, worth a combined $1.24B — up 5.3% from $1.17B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ZYME positions and 23 closed out — a net gain of 17 holders — while 51 added to existing stakes and 28 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $28.7M. The largest seller was Farallon Capital Management, cutting an estimated $44.2M.
- 133 institutional investors held Zymeworks (ZYME) as of Q2 2020, up from 116 in Q1 2020.
- Funds reported $1.24B of Zymeworks stock for Q2 2020, up 5.3% quarter-over-quarter.
- 40 funds opened new Zymeworks positions in Q2 2020 and 23 closed out, a net change of +17 holders.
- The largest Zymeworks buyer in Q2 2020 was Armistice Capital, an estimated $28.7M added.
- The largest Zymeworks seller in Q2 2020 was Farallon Capital Management, an estimated $44.2M sold.
Based on aggregated 13F filings for Q2 2020.